Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mavacoxib

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 170569-88-7, Trocoxil, Pha-739521, Pha 739,521, Yft7x7sr77, Chembl28527
    Molecular Formula
    C16H11F4N3O2S
    Molecular Weight
    385.3  g/mol
    InChI Key
    TTZNQDOUNXBMJV-UHFFFAOYSA-N
    FDA UNII
    YFT7X7SR77
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
    2.1.2 InChI
    InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)
    2.1.3 InChI Key
    TTZNQDOUNXBMJV-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F
    2.2 Other Identifiers
    2.2.1 UNII
    YFT7X7SR77
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide

    2.3.2 Depositor-Supplied Synonyms

    1. 170569-88-7

    2. Trocoxil

    3. Pha-739521

    4. Pha 739,521

    5. Yft7x7sr77

    6. Chembl28527

    7. 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide

    8. Chebi:76207

    9. Mavacoxib (usan)

    10. Mavacoxib [usan]

    11. 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide

    12. 4-[5-(4-fluoro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide

    13. 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]benzenesulfonamide

    14. Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)-

    15. Mavacoxib [usan:inn]

    16. Unii-yft7x7sr77

    17. Mavacoxibum

    18. 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

    19. Mavacoxib [inn]

    20. Mavacoxib [mi]

    21. Schembl212699

    22. Dtxsid90168880

    23. Bcp15454

    24. Zinc3814698

    25. Bdbm50057564

    26. Mfcd28138640

    27. S6685

    28. Akos030241943

    29. At19475

    30. Mavacoxib [ema Epar Veterinary]

    31. Ncgc00510931-01

    32. As-78391

    33. Hy-119447

    34. Cs-0068402

    35. D04863

    36. E-6113

    37. Q6794110

    38. 4-[5-(4-fluorophenyl)-3-trifluoromethyl-1h-pyrazol-1-yl]benzenesulfonamide

    39. 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]-benzenesulfonamide

    40. Pha-739521; Pha739521; Pha 739521; Pha 739,521; Pha739,521; Pha-739,521

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 385.3 g/mol
    Molecular Formula C16H11F4N3O2S
    XLogP33.1
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count3
    Exact Mass385.05081042 g/mol
    Monoisotopic Mass385.05081042 g/mol
    Topological Polar Surface Area86.4 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity579
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    For the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    QM01AH92